AU2274799A - Intermediates in macrolide production - Google Patents

Intermediates in macrolide production

Info

Publication number
AU2274799A
AU2274799A AU22747/99A AU2274799A AU2274799A AU 2274799 A AU2274799 A AU 2274799A AU 22747/99 A AU22747/99 A AU 22747/99A AU 2274799 A AU2274799 A AU 2274799A AU 2274799 A AU2274799 A AU 2274799A
Authority
AU
Australia
Prior art keywords
intermediates
macrolide production
macrolide
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22747/99A
Inventor
Immaculada Bosch
Victor Centellas
Jose Diago
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz Industrial Products SA
Original Assignee
Biochemie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9726992.2A external-priority patent/GB9726992D0/en
Priority claimed from GBGB9726991.4A external-priority patent/GB9726991D0/en
Application filed by Biochemie SA filed Critical Biochemie SA
Publication of AU2274799A publication Critical patent/AU2274799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU22747/99A 1997-12-22 1998-12-18 Intermediates in macrolide production Abandoned AU2274799A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9726992.2A GB9726992D0 (en) 1997-12-22 1997-12-22 Organic compounds
GBGB9726991.4A GB9726991D0 (en) 1997-12-22 1997-12-22 Organic compounds
GB9726991 1997-12-22
GB9726992 1997-12-22
PCT/EP1998/008320 WO1999032500A2 (en) 1997-12-22 1998-12-18 Intermediates in macrolide production

Publications (1)

Publication Number Publication Date
AU2274799A true AU2274799A (en) 1999-07-12

Family

ID=26312817

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22747/99A Abandoned AU2274799A (en) 1997-12-22 1998-12-18 Intermediates in macrolide production

Country Status (3)

Country Link
AU (1) AU2274799A (en)
ES (1) ES2177448B1 (en)
WO (1) WO1999032500A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100317907B1 (en) * 1998-11-24 2001-12-24 김 완 주 Novel Intermediates, process for preparing macrolide antibiotic agent therefrom
KR100361397B1 (en) * 2000-03-15 2002-11-23 한미약품공업 주식회사 Process for producing clarithromycin using erythromycin a 9-o-tropyloxime derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534588B2 (en) * 1982-10-15 1985-09-20 Roussel Uclaf NOVEL OXIMES DERIVED FROM ERYTHROMYCIN, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
DE69227713D1 (en) * 1991-03-15 1999-01-14 Merck & Co Inc 9-Deoxo-9 (Z) -hydroxyiminoerythromycin A and O derivatives thereof
US5837829A (en) * 1996-04-02 1998-11-17 Abbott Laboratories 9-oximesilyl erythromycin a derivatives

Also Published As

Publication number Publication date
WO1999032500A2 (en) 1999-07-01
ES2177448A1 (en) 2002-12-01
ES2177448B1 (en) 2004-08-01
WO1999032500A3 (en) 1999-09-02

Similar Documents

Publication Publication Date Title
AU5430499A (en) Photobioreactor
AU1709299A (en) Mixer-injectors
AU9277698A (en) 9-amino-3-keto erythromycin derivatives
AU6598798A (en) Resorcinyl-triazines
AU1027499A (en) 32P-polyphosphazene
AU2623899A (en) Novel thiobenzamides
AU4139799A (en) Improvements in macrolide production
AU2350199A (en) Novel aminoorganofunctionalsiloxanes
AU5272198A (en) EMP-charge-eliminator
AUPO900097A0 (en) Process
EP0903415A3 (en) Structure expansée
AU9551498A (en) Process
AU6998698A (en) Dioxacycloalkan-8-one
AU4117497A (en) Micropolarimeter
AU4037699A (en) Novel aryl-hydro naphthalenal kanamines
AU6185898A (en) Clavaspirins
AU1867799A (en) Spacer
AU8925398A (en) 3-descladinose 6-o-substituded erythromycin derivatives
AU1442699A (en) Can shaping
AU6932098A (en) Erythromycin derivatives
AU1161500A (en) Macrolide intermediates
AU1504899A (en) Erythromycin derivatives
AU2274799A (en) Intermediates in macrolide production
AU2724799A (en) Novel endo-xylogalacturonase
AU7226598A (en) Stay

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase